Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.77
-0.03
(-1.07%)
After-Hours: 04:22
Ovid Therapeutics Price : 2.80 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 2.87 | 2.93 | 2.76 | 2.80 | 1.674M |
| Aug 27, 2026 | 2.85 | 2.95 | 2.83 | 2.93 | 1.723M |
| Aug 26, 2026 | 2.905 | 2.93 | 2.845 | 2.88 | 1.143M |
| Aug 25, 2026 | 2.85 | 2.94 | 2.815 | 2.91 | 1.450M |
| Aug 24, 2026 | 2.79 | 2.86 | 2.67 | 2.82 | 1.230M |
| Aug 21, 2026 | 2.76 | 2.83 | 2.71 | 2.80 | 1.332M |
| Aug 20, 2026 | 2.88 | 2.93 | 2.72 | 2.74 | 1.146M |
| Aug 19, 2026 | 2.90 | 2.95 | 2.84 | 2.93 | 2.876M |
| Aug 18, 2026 | 2.87 | 2.905 | 2.795 | 2.84 | 1.935M |
| Aug 17, 2026 | 2.83 | 2.92 | 2.80 | 2.89 | 1.748M |
| Aug 14, 2026 | 2.80 | 2.87 | 2.745 | 2.83 | 1.241M |
| Aug 13, 2026 | 2.65 | 2.875 | 2.62 | 2.80 | 2.243M |
| Aug 12, 2026 | 2.44 | 2.645 | 2.43 | 2.62 | 931468.0 |
| Aug 11, 2026 | 2.62 | 2.65 | 2.525 | 2.58 | 903203.0 |
| Aug 10, 2026 | 2.59 | 2.62 | 2.53 | 2.62 | 1.252M |
| Aug 07, 2026 | 2.69 | 2.69 | 2.60 | 2.63 | 919698.0 |
| Aug 06, 2026 | 2.62 | 2.685 | 2.585 | 2.65 | 1.294M |
| Aug 05, 2026 | 2.52 | 2.68 | 2.49 | 2.62 | 2.254M |
| Aug 04, 2026 | 2.33 | 2.555 | 2.33 | 2.54 | 1.666M |
| Aug 03, 2026 | 2.222 | 2.36 | 2.222 | 2.33 | 1.677M |
| Jul 31, 2026 | 2.36 | 2.36 | 2.20 | 2.22 | 1.745M |
| Jul 30, 2026 | 2.30 | 2.375 | 2.275 | 2.37 | 1.286M |
| Jul 29, 2026 | 2.35 | 2.40 | 2.255 | 2.29 | 648339.0 |
| Jul 28, 2026 | 2.42 | 2.42 | 2.24 | 2.36 | 1.351M |
| Jul 27, 2026 | 2.35 | 2.485 | 2.31 | 2.35 | 1.048M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.26 |
| Vericel Corp. | 40.95 |
Price Related Metrics
| PS Ratio | 215.09 |
| Price to Book Value | 2.465 |
| Earnings Yield | -9.05% |
| Market Cap | 517.32M |